Ibogaine and Opiates

Ibogaine is the only known substance with the ability to eliminate the withdrawal symptoms of opiate detoxification. Through neurobiological actions, Ibogaine and its metabolite noribogaine stop the effects of tolerance, erasing the chemical memory of opiates and ending withdrawal symptoms.

This process involves the agonization of two neural receptor sites in the brain, Mu and Kappa. These sites cause the analgesia, euphoria, drowsiness, slowed respiration and metabolic functions associated with opiate use. Noribogaine works to combat the effects of opiate addiction by “reseting” the Mu and Kappa receptor sites. This ends the effects of tolerance, which dictates the release of neural agents responsible for mood regulation and physical wellbeing.

The receptor site reset allows for the effects of opiates on receptors to be erased while still preserving original neural functions, improving pragmatic memory recall and enhancing the individual’s ability to access the formative impressions consciously imbedded by actual life events.

Currently, much current scientific literature claims that the neurobiological actions that occur in the brain are not completely understood and that many aspects of the Ibogaine compound remain unknown. We do know, however, that when a user ingests sufficient amounts of Ibogaine, a reset occurs in the neurobiology of an opiate addict, relieving the physical and mental symptoms and effects of tolerance and withdrawal.




© 2015 Lex Kogan Ibogaine Treatment